Komori
Fuji Pharma (4554) · RiskMitigated

Impairment Risk Relating to OLIC’s Goodwill

First written in FY2017. 4 of 8 entries say "Restated". Latest entry: FY2025-H1.

8entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY2022MitigatedFY2024-Q1 – FY2025-H12017: 12018: 120182019: 020192020: 120202021: 120212022: 120222023: 020232024: 220242025: 12025
Same theme, other companies
Impairment of Goodwill and Trademark Rights Associated with AcquisitionsA theme 207 companies write about · 209 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2023: 35 of 97 companies on the "Worse" side.

32 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 209 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1MitigatedAnnual report

    「Goodwill 88 -」

    OLIC goodwill declined from ¥88 million at the end of the previous consolidated fiscal year to zero, eliminating the balance subject to goodwill impairment risk.
  2. FY2024-Q2MitigatedAnnual report

    「Goodwill 412 251」

    The goodwill balance declined from ¥412 million at the end of the previous consolidated fiscal year to ¥251 million, reducing the balance subject to the impairment risk associated with OLIC goodwill.
  3. FY2024-Q1MitigatedAnnual report

    「Goodwill 412 332」

    The goodwill balance declined from ¥412 million at the end of the previous consolidated fiscal year to ¥332 million, reducing the balance subject to the impairment risk associated with OLIC goodwill.
  4. FY2022RestatedAnnual report

    「Goodwill on the consolidated balance sheet at the end of the current consolidated fiscal year amounted to ¥691 million. Like other fixed assets, goodwill is subject to impairment accounting. If the profitability of OLIC (Thailand) Limited declines due to significant changes in the business environment or business operations, the resulting goodwill impairment loss could affect the operating results and financial position of our Group.」

    Continues to describe the impairment risk associated with OLIC goodwill and discloses a goodwill balance of ¥691 million.
  5. FY2021RestatedAnnual report

    「Goodwill on the consolidated balance sheet at the end of the current consolidated fiscal year amounted to ¥865 million. Like other fixed assets, goodwill is subject to impairment accounting. If the profitability of OLIC (Thailand) Limited declines due to significant changes in the business environment or business operations, the resulting goodwill impairment loss could affect the operating results and financial position of our Group.」

    Discloses that the impairment risk associated with OLIC goodwill continues to be described and that the goodwill balance has reached ¥865 million.
  6. FY2020RestatedAnnual report

    「Goodwill on the consolidated balance sheet at the end of the current consolidated fiscal year amounted to ¥1,144 million. Like other fixed assets, goodwill is subject to impairment accounting. If the profitability of OLIC declines due to significant changes in the business environment or business operations, the resulting goodwill impairment loss could affect the operating results and financial position of our Group.」

    Continues to describe the impairment risk associated with OLIC goodwill, with the goodwill balance standing at ¥1,144 million.
  7. FY2018RestatedAnnual report

    「We plan to amortize the goodwill recognized on a straight-line basis over 12 years. Goodwill on the consolidated balance sheet at the end of the current consolidated fiscal year amounted to ¥1,764 million. Like other fixed assets, goodwill is subject to impairment accounting. If the profitability of OLIC declines due to significant changes in the business environment or business operations, the resulting goodwill impairment loss could affect the operating results and financial position of our Group.」

    Continues to describe the impairment risk associated with OLIC goodwill. The goodwill balance declined from ¥1,976 million in the previous fiscal year to ¥1,764 million. The policy of straight-line amortization over 12 years is also specified.
  8. FY2017First statedAnnual report

    「Goodwill on the consolidated balance sheet at the end of the current consolidated fiscal year amounted to ¥1,976 million. Like other fixed assets, goodwill is subject to impairment accounting. If the profitability of OLIC declines due to significant changes in the business environment or business operations, the resulting goodwill impairment loss could affect the operating results and financial position of our Group.」

    Describes the risk of an impairment loss if the profitability of the ¥1,976 million in goodwill recognized in connection with the acquisition of OLIC declines.
Moved together

"Expanding the market share of core products in the priority obstetrics and gynecology field" moved the same way as this thread, in the same document, in 3 of its 8 moves.

322222★123456
  1. ★This thread
  2. 1Expanding the market share of core products in the priority obstetrics and gynecology field3×
  3. 2Early development and launch of new drugs, biosimilars and value-added generics2×
  4. 3Launching Multiple Products and Becoming No. 1 in Japan’s Biosimilar Market2×
  5. 4Expansion of the APAC CMO Business Driven by OLIC’s New Injectable Drug Manufacturing Facility2×
  6. 5Expansion of sales of radiology products and transferred products2×
  7. 6Review of Strategic Shareholdings Based on Medium- to Long-Term Enhancement of Corporate Value2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment Risk Relating to OLIC’s Goodwill | Fuji Pharma Co.,Ltd. (4554) | Komori